Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small Toxic Molecule Detection and Elimination Using Molecularly Imprinted Polymers (MIPs).

Biosensors·2025
Same author

Nanofiber-Based Biomimetic Platforms for Chronic Wound Healing: Recent Innovations and Future Directions.

Tissue engineering and regenerative medicine·2025
Same author

Recent Advances in Electrochemical Biosensors for Neurodegenerative Disease Biomarkers.

Biosensors·2025
Same author

Harnessing the Intradermal Delivery of Hair Follicle Dermal Papilla Cell Spheroids for Hair Follicle Regeneration in Nude Mice.

Biomaterials research·2025
Same author

Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis.

Acta pharmaceutica Sinica. B·2025
Same author

Flexible Electrochemical Biosensor Using Nanostructure-Modified Polymer Electrode for Detection of Viral Nucleic Acids.

Biosensors·2024

Related Experiment Video

Updated: May 20, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Plasmonic Biosensors in Cancer-Associated miRNA Detection.

Nayoung Kim1, Mingyu Bae1, Euni Cho1

  • 1Department of Information Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea.

Biosensors
|March 26, 2025
PubMed
Summary

Advanced plasmonic biosensors offer sensitive detection of cancer-associated microRNAs (miRNAs) for early diagnosis. This review highlights recent innovations in plasmonic sensing strategies and nanomaterials for improved cancer detection and treatment monitoring.

Keywords:
biosensorcancerlocalized surface plasmon resonancemiRNAplasmonic enhanced fluorescentsurface plasmon resonance

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.2K

Related Experiment Videos

Last Updated: May 20, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.2K

Area of Science:

  • Biomedical Engineering
  • Molecular Diagnostics
  • Nanotechnology

Background:

  • Cancer remains a leading cause of death, necessitating improved early diagnostic methods.
  • MicroRNAs (miRNAs) are crucial biomarkers for cancer detection, prognosis, and monitoring due to their specificity and stability.
  • Plasmonic biosensors offer high sensitivity and selectivity for biomarker analysis.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements (approx. last 5 years) in plasmonic biosensor technology for cancer-associated miRNA detection.
  • To highlight emerging plasmonic sensing strategies, novel nanomaterials, and signal amplification techniques.
  • To explore the potential of these innovations in improving cancer diagnosis and treatment.

Main Methods:

  • Review of recent scientific literature focusing on plasmonic biosensors and miRNA detection.
  • Emphasis on innovative sensing strategies, nanomaterial integration, and signal amplification methods.
  • Analysis of advancements within the last five years.

Main Results:

  • Significant progress in plasmonic biosensor sensitivity and selectivity for miRNA detection.
  • Integration of novel nanomaterials enhances biosensor performance.
  • Advanced signal amplification techniques improve detection limits.
  • Emerging strategies show promise for clinical translation.

Conclusions:

  • Plasmonic biosensors represent a powerful tool for sensitive and selective detection of cancer-associated miRNAs.
  • Recent innovations in materials and techniques are rapidly advancing the field.
  • These developments hold significant potential for improving early cancer diagnosis and patient management.